carvedilolhexal 25 mg tablett
hexal ag - karvedilool - tablett - 25mg 30tk; 25mg 100tk
carvedilolhexal 12,5 mg tablett
hexal ag - karvedilool - tablett - 12,5mg 30tk; 12,5mg 60tk; 12,5mg 50tk
co-ramicor 5 mg/25 mg tablett
hexal ag - ramipriil+hüdroklorotiasiid - tablett - 5mg+25mg 30tk; 5mg+25mg 100tk
ramicor 10 mg tablett
hexal ag - ramipriil - tablett - 10mg 60tk; 10mg 30tk; 10mg 20tk; 10mg 100tk; 10mg 250tk; 10mg 28tk
enahexal 10 mg tablett
hexal ag - enalapriil - tablett - 10mg 100tk; 10mg 60tk
co-ramicor 2,5 mg/12,5 mg tablett
hexal ag - ramipriil+hüdroklorotiasiid - tablett - 2,5mg+12,5mg 30tk; 2,5mg+12,5mg 60tk; 2,5mg+12,5mg 100tk
enahexal 20 mg tablett
hexal ag - enalapriil - tablett - 20mg 60tk; 20mg 30tk; 20mg 100tk
enahexal comp 20 mg/12,5 mg tablett
hexal ag - enalapriil+hüdroklorotiasiid - tablett - 20mg+12,5mg 60tk; 20mg+12,5mg 30tk
raxone
chiesi farmaceutici s.p.a - idebenoon - optika atroofia, pärilik, leber - muud psychostimulants ja nootroopikumid, psychoanaleptics, - raxone on näidustatud leberi päriliku optilise neuropaatia (lhon) noorukite ja täiskasvanud patsientide nägemiskahjustuse raviks.
padcev
astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - antineoplastilised ained - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.